Tag Archives: could

With safety data, Bayer could challenge Erleada, Xtandi in prostate cancer: analyst

For years, Johnson & Johnson and the Pfizer-Astellas team have been the only players in their class of prostate-cancer fighters. But Bayer is waiting in the wings, and stellar new safety data could make it a threat. The German drugmaker trumpeted phase 3 data Thursday on its androgen receptor antagonist candidate, darolutamide, showing that the drug… Read More »

EDs could save $8.3B annually with better primary care, study finds

Dive Brief: More effective primary care could save emergency departments an estimated $ 8.3 billion annually, according to a new Premier analysis. Of 24 million visits by patients with certain chronic conditions in 2017, 4.3 million were potentially avoidable. Patients with those conditions contributed to nearly 60% of all ED visits at nearly 750 hospitals… Read More »